Fentanyl Sandoz matrixpleister 75 µg/uur
As listed in the register: Fentanyl Sandoz matrixpleister 75 µg/uur, pleisters voor transdermaal gebruik
75 µg · pleister voor transdermaal gebruik
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Fentanyl
- Made by
- Sandoz B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (FENTANYL). It describes the substance, not this exact product.
Fentanyl is an opioid agonist.
Fentanyl interacts predominately with the opioid mu-receptor.
Fentanyl is metabolized primarily via human cytochrome P450 3A4 isoenzyme system.
Within 72 hours of IV fentanyl administration, approximately 75% of the dose is excreted in urine, mostly as metabolites with less than 10% representing unchanged drug.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-07
Safety of the active substance
From the US prescribing label for the same active substance (FENTANYL). It describes the substance, not this exact product.
Life-threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of fentanyl transdermal system, especially during initiation or following a dose increase.
- Opioid non-tolerant patients.
- ( 4 ) Acute or intermittent pain, postoperative pain, mild pain.
- ( 4 ) Significant respiratory depression.
- ( 4 ) Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment.
The most common adverse reactions (≥5%) in a double-blind, randomized, placebo-controlled clinical trial in patients with severe pain were nausea, vomiting, somnolence, dizziness, insomnia, constipation, hyperhidrosis, fatigue, feeling cold, and anorexia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Sandoz B.V. |
|---|---|
| Active substance | Fentanyl |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 75 µg |
| Form | pleister voor transdermaal gebruik |
| Classification | N02AB03 · Pain, sleep, mood, epilepsy and the brain |
| Route | transdermaal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Fentanyl Sandoz matrixpleister 75 µg/uur, pleisters voor transdermaal gebruik |
| RVG | 100322 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.